Literature DB >> 23147668

Biological network inference for drug discovery.

Paola Lecca1, Corrado Priami.   

Abstract

A better understanding of the pathophysiology should help deliver drugs whose targets are involved in the causative processes underlying a disease. Biological network inference uses computational methods for deducing from high-throughput experimental data, the topology and the causal structure of the interactions among the drugs and their targets. Therefore, biological network inference can support and contribute to the experimental identification of both gene and protein networks causing a disease as well as the biochemical networks of drugs metabolism and mechanisms of action. The resulting high-level networks serve as a foundational basis for more detailed mechanistic models and are increasingly used in drug discovery by pharmaceutical and biotechnology companies. We review and compare recent computational technologies for network inference applied to drug discovery.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Mesh:

Year:  2012        PMID: 23147668     DOI: 10.1016/j.drudis.2012.11.001

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  11 in total

1.  An In Silico Method for Predicting Drug Synergy Based on Multitask Learning.

Authors:  Xin Chen; Lingyun Luo; Cong Shen; Pingjian Ding; Jiawei Luo
Journal:  Interdiscip Sci       Date:  2021-02-21       Impact factor: 2.233

2.  Systems toxicology: from basic research to risk assessment.

Authors:  Shana J Sturla; Alan R Boobis; Rex E FitzGerald; Julia Hoeng; Robert J Kavlock; Kristin Schirmer; Maurice Whelan; Martin F Wilks; Manuel C Peitsch
Journal:  Chem Res Toxicol       Date:  2014-01-21       Impact factor: 3.739

Review 3.  Metabolic network discovery by top-down and bottom-up approaches and paths for reconciliation.

Authors:  Tunahan Cakır; Mohammad Jafar Khatibipour
Journal:  Front Bioeng Biotechnol       Date:  2014-12-03

4.  Ligand-target prediction by structural network biology using nAnnoLyze.

Authors:  Francisco Martínez-Jiménez; Marc A Marti-Renom
Journal:  PLoS Comput Biol       Date:  2015-03-27       Impact factor: 4.475

5.  Efficient randomization of biological networks while preserving functional characterization of individual nodes.

Authors:  Francesco Iorio; Marti Bernardo-Faura; Andrea Gobbi; Thomas Cokelaer; Giuseppe Jurman; Julio Saez-Rodriguez
Journal:  BMC Bioinformatics       Date:  2016-12-20       Impact factor: 3.169

6.  Enabling network inference methods to handle missing data and outliers.

Authors:  Abel Folch-Fortuny; Alejandro F Villaverde; Alberto Ferrer; Julio R Banga
Journal:  BMC Bioinformatics       Date:  2015-09-03       Impact factor: 3.169

Review 7.  Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery.

Authors:  Douglas B Kell; Royston Goodacre
Journal:  Drug Discov Today       Date:  2013-07-26       Impact factor: 7.851

8.  MIDER: network inference with mutual information distance and entropy reduction.

Authors:  Alejandro F Villaverde; John Ross; Federico Morán; Julio R Banga
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

9.  Functional association networks as priors for gene regulatory network inference.

Authors:  Matthew E Studham; Andreas Tjärnberg; Torbjörn E M Nordling; Sven Nelander; Erik L L Sonnhammer
Journal:  Bioinformatics       Date:  2014-06-15       Impact factor: 6.937

10.  SBMLsqueezer 2: context-sensitive creation of kinetic equations in biochemical networks.

Authors:  Andreas Dräger; Daniel C Zielinski; Roland Keller; Matthias Rall; Johannes Eichner; Bernhard O Palsson; Andreas Zell
Journal:  BMC Syst Biol       Date:  2015-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.